author_facet Moreno, Natalia
Holsten, Till
Mertins, Julius
Zhogbi, Annabelle
Johann, Pascal
Kool, Marcel
Meisterernst, Michael
Kerl, Kornelius
Moreno, Natalia
Holsten, Till
Mertins, Julius
Zhogbi, Annabelle
Johann, Pascal
Kool, Marcel
Meisterernst, Michael
Kerl, Kornelius
author Moreno, Natalia
Holsten, Till
Mertins, Julius
Zhogbi, Annabelle
Johann, Pascal
Kool, Marcel
Meisterernst, Michael
Kerl, Kornelius
spellingShingle Moreno, Natalia
Holsten, Till
Mertins, Julius
Zhogbi, Annabelle
Johann, Pascal
Kool, Marcel
Meisterernst, Michael
Kerl, Kornelius
Oncotarget
Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
Oncology
author_sort moreno, natalia
spelling Moreno, Natalia Holsten, Till Mertins, Julius Zhogbi, Annabelle Johann, Pascal Kool, Marcel Meisterernst, Michael Kerl, Kornelius 1949-2553 Impact Journals, LLC Oncology http://dx.doi.org/10.18632/oncotarget.18583 Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors Oncotarget
doi_str_mv 10.18632/oncotarget.18583
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTg2MzIvb25jb3RhcmdldC4xODU4Mw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTg2MzIvb25jb3RhcmdldC4xODU4Mw
institution DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
imprint Impact Journals, LLC, 2017
imprint_str_mv Impact Journals, LLC, 2017
issn 1949-2553
issn_str_mv 1949-2553
language English
mega_collection Impact Journals, LLC (CrossRef)
match_str moreno2017combinedbrd4andcdk9inhibitionasanewtherapeuticapproachinmalignantrhabdoidtumors
publishDateSort 2017
publisher Impact Journals, LLC
recordtype ai
record_format ai
series Oncotarget
source_id 49
title Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_unstemmed Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_full Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_fullStr Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_full_unstemmed Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_short Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_sort combined brd4 and cdk9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
topic Oncology
url http://dx.doi.org/10.18632/oncotarget.18583
publishDate 2017
physical 84986-84995
description
container_issue 49
container_start_page 84986
container_title Oncotarget
container_volume 8
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792341726845730821
geogr_code not assigned
last_indexed 2024-03-01T16:24:17.351Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Combined+BRD4+and+CDK9+inhibition+as+a+new+therapeutic+approach+in+malignant+rhabdoid+tumors&rft.date=2017-10-17&genre=article&issn=1949-2553&volume=8&issue=49&spage=84986&epage=84995&pages=84986-84995&jtitle=Oncotarget&atitle=Combined+BRD4+and+CDK9+inhibition+as+a+new+therapeutic+approach+in+malignant+rhabdoid+tumors&aulast=Kerl&aufirst=Kornelius&rft_id=info%3Adoi%2F10.18632%2Foncotarget.18583&rft.language%5B0%5D=eng
SOLR
_version_ 1792341726845730821
author Moreno, Natalia, Holsten, Till, Mertins, Julius, Zhogbi, Annabelle, Johann, Pascal, Kool, Marcel, Meisterernst, Michael, Kerl, Kornelius
author_facet Moreno, Natalia, Holsten, Till, Mertins, Julius, Zhogbi, Annabelle, Johann, Pascal, Kool, Marcel, Meisterernst, Michael, Kerl, Kornelius, Moreno, Natalia, Holsten, Till, Mertins, Julius, Zhogbi, Annabelle, Johann, Pascal, Kool, Marcel, Meisterernst, Michael, Kerl, Kornelius
author_sort moreno, natalia
container_issue 49
container_start_page 84986
container_title Oncotarget
container_volume 8
description
doi_str_mv 10.18632/oncotarget.18583
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTg2MzIvb25jb3RhcmdldC4xODU4Mw
imprint Impact Journals, LLC, 2017
imprint_str_mv Impact Journals, LLC, 2017
institution DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15
issn 1949-2553
issn_str_mv 1949-2553
language English
last_indexed 2024-03-01T16:24:17.351Z
match_str moreno2017combinedbrd4andcdk9inhibitionasanewtherapeuticapproachinmalignantrhabdoidtumors
mega_collection Impact Journals, LLC (CrossRef)
physical 84986-84995
publishDate 2017
publishDateSort 2017
publisher Impact Journals, LLC
record_format ai
recordtype ai
series Oncotarget
source_id 49
spelling Moreno, Natalia Holsten, Till Mertins, Julius Zhogbi, Annabelle Johann, Pascal Kool, Marcel Meisterernst, Michael Kerl, Kornelius 1949-2553 Impact Journals, LLC Oncology http://dx.doi.org/10.18632/oncotarget.18583 Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors Oncotarget
spellingShingle Moreno, Natalia, Holsten, Till, Mertins, Julius, Zhogbi, Annabelle, Johann, Pascal, Kool, Marcel, Meisterernst, Michael, Kerl, Kornelius, Oncotarget, Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors, Oncology
title Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_full Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_fullStr Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_full_unstemmed Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_short Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_sort combined brd4 and cdk9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
title_unstemmed Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
topic Oncology
url http://dx.doi.org/10.18632/oncotarget.18583